Terms: = Gastric cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Treatment
30 results:
1. Development and validation of a preoperative risk nomogram prediction model for gastric gastrointestinal stromal tumors.
Liu Z; Gao J; Zeng C; Chen Y
Surg Endosc; 2024 Apr; 38(4):1933-1943. PubMed ID: 38334780
[TBL] [Abstract] [Full Text] [Related]
2. Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer.
Nishikawa K; Kawakami H; Shimokawa T; Fujitani K; Tamura S; Endo S; Kobayashi M; Kawada J; Kurokawa Y; Tsuburaya A; Yoshikawa T; Sakamoto J; Satoh T;
Int J Clin Oncol; 2023 Nov; 28(11):1501-1510. PubMed ID: 37634209
[TBL] [Abstract] [Full Text] [Related]
3. Cost-effectiveness analysis of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with gastric cancer and peritoneal metastasis.
Javanbakht M; Mashayekhi A; Branagan-Harris M; Horvath P; Königsrainer A; Reymond MA; Yaghoubi M
Eur J Surg Oncol; 2022 Jan; 48(1):188-196. PubMed ID: 34479745
[TBL] [Abstract] [Full Text] [Related]
4. Differentiated/undifferentiated mixed type is a prognostic factor for T2/T3 gastric cancer patients.
Lu H; Sun Y; Zhu Z; Xu H; Huang R; Huang B
Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1329-1336. PubMed ID: 34431734
[TBL] [Abstract] [Full Text] [Related]
5. From Lauren's diffuse gastric cancer to WHO's poorly cohesive carcinoma. Clinicopathological and prognostic characteristics.
Sarriugarte Lasarte A; García Alberdi E; Martínez Indart L; Gutiérrez Grijalba O; Álvarez Abad I; Guerra Lerma M; Calle Baraja M; Colina Alonso A
Rev Esp Enferm Dig; 2021 May; 113(5):324-331. PubMed ID: 33228367
[TBL] [Abstract] [Full Text] [Related]
6. β-Elemene inhibits the metastasis of multidrug-resistant gastric cancer cells through miR-1323/Cbl-b/EGFR pathway.
Deng M; Liu B; Song H; Yu R; Zou D; Chen Y; Ma Y; Lv F; Xu L; Zhang Z; Lv Q; Yang X; Che X; Qu X; Liu Y; Zhang Y; Hu X
Phytomedicine; 2020 Apr; 69():153184. PubMed ID: 32199253
[TBL] [Abstract] [Full Text] [Related]
7. Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study.
Fanotto V; Fornaro L; Bordonaro R; Rosati G; Rimassa L; Di Donato S; Santini D; Tomasello G; Leone F; Silvestris N; Stragliotto S; Scartozzi M; Giampieri R; Nichetti F; Antonuzzo L; Cinieri S; Avallone A; Pellegrino A; Melisi D; Vasile E; Gerratana L; Aprile G
J Geriatr Oncol; 2019 Jul; 10(4):591-597. PubMed ID: 30551958
[TBL] [Abstract] [Full Text] [Related]
8. Bufalin induces protective autophagy by Cbl-b regulating mTOR and ERK signaling pathways in gastric cancer cells.
Qi HY; Qu XJ; Liu J; Hou KZ; Fan YB; Che XF; Liu YP
Cell Biol Int; 2019 Jan; 43(1):33-43. PubMed ID: 30468278
[TBL] [Abstract] [Full Text] [Related]
9. MiR-940 promotes the proliferation and migration of gastric cancer cells through up-regulation of programmed death ligand-1 expression.
Fan Y; Che X; Hou K; Zhang M; Wen T; Qu X; Liu Y
Exp Cell Res; 2018 Dec; 373(1-2):180-187. PubMed ID: 30367831
[TBL] [Abstract] [Full Text] [Related]
10. [The value of (18)F-FDG PET-CT imaging in predicting the malignant potential of GIST].
Li SX; Tang MD; Lin DY; Liu DJ; Lyu QH; Zhang JP; Cai ZH
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):821-827. PubMed ID: 29151288
[No Abstract] [Full Text] [Related]
11. DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells.
Xu L; Zhang Y; Qu X; Che X; Guo T; Li C; Ma R; Fan Y; Ma Y; Hou K; Li D; Hu X; Liu B; Yu R; Yan H; Gong J; Liu Y
Mol Oncol; 2017 Dec; 11(12):1733-1751. PubMed ID: 28972304
[TBL] [Abstract] [Full Text] [Related]
12. Outcomes of Advanced gastric cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Fanotto V; Uccello M; Pecora I; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Ferrari L; Bordonaro R; Vivaldi C; Gerratana L; Bozzarelli S; Filippi R; Bilancia D; Russano M; Aprile G
Oncologist; 2017 Dec; 22(12):1463-1469. PubMed ID: 28860412
[TBL] [Abstract] [Full Text] [Related]
13. E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant gastric and Breast cancer Cells.
Xu L; Zhang Y; Qu X; Che X; Guo T; Cai Y; Li A; Li D; Li C; Wen T; Fan Y; Hou K; Ma Y; Hu X; Liu Y
Neoplasia; 2017 Apr; 19(4):374-382. PubMed ID: 28334634
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
Fanotto V; Cordio S; Pasquini G; Fontanella C; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Torri V; Aprile G
Gastric Cancer; 2017 Sep; 20(5):825-833. PubMed ID: 28028664
[TBL] [Abstract] [Full Text] [Related]
15. Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting.
Bouchet S; Poulette S; Titier K; Moore N; Lassalle R; Abouelfath A; Italiano A; Chevreau C; Bompas E; Collard O; Duffaud F; Rios M; Cupissol D; Adenis A; Ray-Coquard I; Bouché O; Le Cesne A; Bui B; Blay JY; Molimard M
Eur J Cancer; 2016 Apr; 57():31-8. PubMed ID: 26851399
[TBL] [Abstract] [Full Text] [Related]
16. Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway.
Cao Y; Qu J; Li C; Yang D; Hou K; Zheng H; Liu Y; Qu X
Tumour Biol; 2015 Jul; 36(7):5607-15. PubMed ID: 25701378
[TBL] [Abstract] [Full Text] [Related]
17. Cbl-b accelerates trypsin-induced cell detachment through ubiquitination and degradation of proline-rich tyrosine kinase 2.
Fan Y; Qu X; Ma Y; Qu J; Liu Y; Hu X
Tumour Biol; 2014 Nov; 35(11):11129-35. PubMed ID: 25099615
[TBL] [Abstract] [Full Text] [Related]
18. Cbl-b enhances sensitivity to 5-fluorouracil via EGFR- and mitochondria-mediated pathways in gastric cancer cells.
Feng D; Ma Y; Liu J; Xu L; Zhang Y; Qu J; Liu Y; Qu X
Int J Mol Sci; 2013 Dec; 14(12):24399-411. PubMed ID: 24351824
[TBL] [Abstract] [Full Text] [Related]
19. Lipid raft-regulated IGF-1R activation antagonizes TRAIL-induced apoptosis in gastric cancer cells.
Xu L; Qu X; Hu X; Zhu Z; Li C; Li E; Ma Y; Song N; Liu Y
FEBS Lett; 2013 Nov; 587(23):3815-23. PubMed ID: 24161672
[TBL] [Abstract] [Full Text] [Related]
20. A multicentre randomised trial comparing weekly paclitaxel + S-1 with weekly paclitaxel + 5-fluorouracil for patients with advanced gastric cancer.
Huang D; Ba Y; Xiong J; Xu N; Yan Z; Zhuang Z; Yu Z; Wan H; Zhang Y; Deng T; Zheng R; Guo Z; Hu C; Wang M; Yu Z; Yao Y; Meng J
Eur J Cancer; 2013 Sep; 49(14):2995-3002. PubMed ID: 23810466
[TBL] [Abstract] [Full Text] [Related]
[Next]
